Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.56−0.01 (-0.39%)
Close on Nov 17, 2026Market cap $285.84MP/E –Yield –
Alector total assets
Total assets on the balance sheet at the end of each period.
Alector's total assets was $202.86M at Jun 30, 2026. For fiscal 2025 it was $293.24M, down 37.4% from the year before. The highest annual figure on record is $814.66M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $293.24M | -37.4% |
| FY2024 | Dec 31, 2024 | $468.30M | -24.7% |
| FY2023 | Dec 31, 2023 | $621.83M | -21.1% |
| FY2022 | Dec 31, 2022 | $787.65M | -3.3% |
| FY2021 | Dec 31, 2021 | $814.66M | +66.9% |
| FY2020 | Dec 31, 2020 | $488.25M | +15.7% |
| FY2019 | Dec 31, 2019 | $421.91M | +36.8% |
| FY2018 | Dec 31, 2018 | $308.36M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $202.86M | -43.1% |
| Q1 FY2026 | Mar 31, 2026 | $239.92M | -41.2% |
| Q4 FY2025 | Dec 31, 2025 | $293.24M | -37.4% |
| Q3 FY2025 | Sep 30, 2025 | $335.29M | -35.0% |
| Q2 FY2025 | Jun 30, 2025 | $356.42M | -37.5% |
| Q1 FY2025 | Mar 31, 2025 | $408.30M | -35.8% |
| Q4 FY2024 | Dec 31, 2024 | $468.30M | -24.7% |
| Q3 FY2024 | Sep 30, 2024 | $516.02M | -23.3% |
| Q2 FY2024 | Jun 30, 2024 | $570.73M | -19.5% |
| Q1 FY2024 | Mar 31, 2024 | $635.49M | -15.1% |
| Q4 FY2023 | Dec 31, 2023 | $621.83M | -21.1% |
| Q3 FY2023 | Sep 30, 2023 | $672.40M | -19.7% |
| Q2 FY2023 | Jun 30, 2023 | $708.74M | -20.3% |
| Q1 FY2023 | Mar 31, 2023 | $748.34M | -21.6% |
| Q4 FY2022 | Dec 31, 2022 | $787.65M | -3.3% |
| Q3 FY2022 | Sep 30, 2022 | $837.04M | -2.0% |
| Q2 FY2022 | Jun 30, 2022 | $889.67M | +124.0% |
| Q1 FY2022 | Mar 31, 2022 | $954.46M | +116.7% |
| Q4 FY2021 | Dec 31, 2021 | $814.66M | +66.9% |
| Q3 FY2021 | Sep 30, 2021 | $854.23M | +60.7% |
| Q2 FY2021 | Jun 30, 2021 | $397.11M | -30.6% |
| Q1 FY2021 | Mar 31, 2021 | $440.36M | -28.9% |
| Q4 FY2020 | Dec 31, 2020 | $488.25M | +15.7% |
| Q3 FY2020 | Sep 30, 2020 | $531.59M | +18.2% |
| Q2 FY2020 | Jun 30, 2020 | $572.03M | +19.9% |
| Q1 FY2020 | Mar 31, 2020 | $618.93M | +24.8% |
| Q4 FY2019 | Dec 31, 2019 | $421.91M | +36.8% |
| Q3 FY2019 | Sep 30, 2019 | $449.73M | – |
| Q2 FY2019 | Jun 30, 2019 | $477.25M | – |
| Q1 FY2019 | Mar 31, 2019 | $496.04M | – |
| Q4 FY2018 | Dec 31, 2018 | $308.36M | – |
See a number that looks wrong?